CClinicalTrials.gg
CompletedNCT04480931Updated Aug 24, 2026Results posted

Pilot Testing a Mobile App to Designed to Increase Physical Activity Among Pregnant and Postpartum Women

An interventional study of mHealth Intervention Group and Educational Brochure in Pregnancy and Postpartum, sponsored by Western Kentucky University. Completed at 1 site in United States. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Western Kentucky University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

The goal of this pilot project is to test the feasibility and potential efficacy of the evidence-based mHealth app (BumptUp) for improving physical activity and subsequent health outcomes (i.e. obesity, hypertension, insulin resistance) among pregnant and postpartum women in a rural community.

In order to accomplish this goal, feasibility of the intervention protocol will be tested by the assessment of recruitment (how many participants eligible per month), retention (% of women who complete the study protocol), adherence to intervention (% of women who utilize the app), and acceptability (survey and one-on-one exit interviews) during pregnancy and postpartum.

Potential efficacy will be determined by examining trends in data on physical activity levels (achieving the goal of 150 minutes per week of physical activity (surveys and accelerometry)) between groups. Other secondary outcomes will also be assessed: weight status, body composition, blood pressure, insulin resistance, fitness levels, mental health, and infant anthropometrics.

Clinical hypotheses:

  1. The mHealth program will be feasible as evidenced by high rates of enrollment, retention, and adherence, moderate-to-high levels of satisfaction, and low participant burden.
  2. The mHealth intervention will show promise towards improving physical activity levels and other secondary outcomes in pregnant and postpartum women in a rural community.
Read the detailed description

After contact is established and eligibility confirmed, Participants (N=40) will be enrolled and baseline surveys will be conducted to collect information about lifestyle, mental health, and anxiety levels. Patient data for those participants who have agreed to be in the study and have specifically agreed on the consent form to allow the study team to pull data from their prenatal charts. The data being pulled from charts will include patient weights, vital signs, blood pressures, current complications, blood analytes, and glucose tolerance test results from each prenatal visit. After the baby is born, delivery reports will also be obtained in order to collect information on the delivery outcomes (gender, mode of delivery, complications, time in labor) and baby's anthropometric data (birthweight, birth length, head circumference).

Compensation will be in the form of Amazon gift cards (delivered electronically). There will be 4 time points where they take the online assessments. At each time point, they will also be mailed an Actigraph accelerometer to wear for one week. These will be sanitized and mailed or dropped off to avoid any contamination from the study team to participants. When the week is over, the study team will check in with participants and discuss a plan for pick up. They can leave outside for a study team member to pick up (contactless ) or they can mail it back (with provided return envelope).

Each participant will still receive a total of $160. They be recruited and consented online around 18-20 weeks. Assessments will occur at 4 timepoints: baseline assessments at 23-25 weeks gestation ($40), phone check at 30 weeks, second assessment/set of surveys at 35-37 weeks ($40), delivery outcomes obtained, 6 week postpartum surveys ($40), and 12 week postpartum surveys ($40).

Statistical Analyses:

Sample Size Determination: Sample size for this pilot study was determined based on previously performed physical activity interventions among pregnant women. The effect size (0.91) for the main outcome of physical activity was determined from looking at post-intervention physical activity data from Asci et al.83. With this effect size, it was determined using SAS software with a type I error rate of 0.05 that a sample size of 20 per group could detect this difference with 80% power, thus our sample size of 15 per group is justified for a pilot project.

Data Analyses:

Aim 1: To estimate the success and feasibility of recruitment methods, the number of people who will hear about the study via various methods (e.g. health care providers, health fairs, word-of-mouth) will be estimated. Then, the number of women who completed initial screening, the number of women who meet the eligibility criteria, the number of women who complete each of the assessments, the number of women randomized, and the number of women who adhere to the intervention will be determined. The exit interview data will be analyzed via standard content analyses for qualitative studies as previously described84 (and recently performed by our group). Aim 2: Although the investigators may not detect all between group differences because the investigators are proposing a pilot project, appropriate statistical tests will be performed in order to examine trends, and thus, promise for effect in the larger future trial. Normality of the distribution for each variable will be tested using Kolmogorov-Smirnov tests, and non-normally distributed data will be transformed as needed. The baseline characteristics of the two groups will be compared using t-tests or Chi square tests. The potential effect of the intervention on study outcomes will be explored using repeated measures ANOVAs (group x time). Specifically, physical activity data between groups will be compared from pre-post intervention. All data will be entered in Redcap data management system. Analyses will be conducted using SAS or other statistical software.

02

Conditions studied

  • Pregnancy
  • Postpartum

Browse trials for

Keywords

  • exercise
  • physical activity
  • mobile health
  • intervention
03

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • 1) Age 18-44
  • 2) Confirmed singleton viable pregnancy
  • 3) English-Speaking (the app is currently only available in English)
  • 4) Physician release to participate in exercise
  • 5) Ownership of a smart phone
  • 6) Plans to deliver at The Medical Center in Bowling Green, KY.

Exclusion criteria

Exclusion Criteria:

  • 1) Multiple gestation pregnancy
  • 2) Inability to provide voluntary informed consent
  • 3) Any medical condition (pregnancy-related or not) that would preclude exercise.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    mHealth Intervention Group

    This group will be provided with the mobile health app (including introductory videos on how to use its features).

    Behavioral: mHealth Intervention Group

  • Sham comparator
    Control Group

    This group will receive an educational brochure about physical activity during pregnancy.

    Behavioral: Educational Brochure

Interventions

  • BehavioralmHealth Intervention Group

    Access to the mobile health application with exercise plans and education

  • BehavioralEducational Brochure

    An evidence-based educational brochure with general information about the benefits of physical activity during pregnancy

05

What researchers measure

Primary outcomes

  1. Protocol Retention

    % of women who complete the study protocol

    Time frame: 12 weeks postpartum

  2. Physical Activity Levels

    Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data

    Time frame: Pregnancy (35-37 weeks gestation)

  3. Physical Activity Levels

    Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data

    Time frame: Postpartum (12 weeks)

06

Results

Posted Aug 24, 2026
Limitations and caveats
Limitations of the study include a small sample size; thus, statistical significance was unlikely to be obtained for many outcomes. In addition, the study population was not very diverse, thus limiting generalizability. Another limitation is the inability to directly determine adherence; the study team was unable to determine (based on app data) who achieved the goal of 150 minutes per week and logged this on the app.

Participant flow

Participant flow — Overall Study
MilestonemHealth Intervention GroupControl Group
Started1919
Completed1718
Not completed21
Withdrew: Lost to follow-up20
Withdrew: Adverse event01

Outcome measures

PrimaryProtocol Retention

% of women who complete the study protocol

Time frame:
12 weeks postpartum
Reported as:
Count of participants · Participants
Protocol Retention
ParticipantsmHealth Intervention GroupControl Group
Protocol Retention1718
PrimaryPhysical Activity Levels

Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data

Time frame:
Pregnancy (35-37 weeks gestation)
Reported as:
Mean · % of time over one week
Physical Activity Levels
% of time over one weekmHealth Intervention GroupControl Group
Physical Activity Levels13.8 ± 5.712.3 ± 4.8
Statistical analysis
  • mHealth Intervention Group vs Control Group · ANOVA · p = <0.05 · Mean difference (final values): -1.41065 · 95% CI -5.02 to 2.2
PrimaryPhysical Activity Levels

Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data

Time frame:
Postpartum (12 weeks)
Reported as:
Mean · % of time over one week
Physical Activity Levels
% of time over one weekmHealth Intervention GroupControl Group
Physical Activity Levels14.6 ± 5.513.8 ± 5.0
Statistical analysis
  • mHealth Intervention Group vs Control Group · ANOVA · p = <0.05 · Mean difference (final values): -.79964 · 95% CI -4.8 to 3.2

Adverse events

Collected over From 23-25 weeks up pregnancy through 12 weeks postpartum. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
mHealth Intervention Group0/17 (0%)0/17 (0%)0/17 (0%)
Control Group0/18 (0%)1/18 (5.6%)0/18 (0%)
Most frequent serious events
Most frequent serious events
EventmHealth Intervention GroupControl Group
infant lossPregnancy, puerperium and perinatal conditions0/171/18

Baseline characteristics

All healthy pregnant women between 23-25 weeks.

Age, Continuous
Age, Continuous(years)mHealth Intervention GroupControl GroupTotal
Mean31.69 ± 4.2230.28 ± 4.7130.94 ± 4.48
Sex: Female, Male
Sex: Female, Male(Participants)mHealth Intervention GroupControl GroupTotal
Female191938
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)mHealth Intervention GroupControl GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White191938
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)mHealth Intervention GroupControl GroupTotal
United States191938
Physical Activity Level
Physical Activity Level(% of time over a week)mHealth Intervention GroupControl GroupTotal
Mean12.5 ± 5.913.5 ± 5.113.0 ± 5.5
07

Study locations

1 site
  • Western Kentucky University
    Bowling Green, Kentucky 42101, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Feb 26, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT04480931
Lead sponsor
Western Kentucky University
Collaborators
University of Kentucky
Responsible party
Rachel Tinius (Assistant Professor, Western Kentucky University) — Principal investigator
First posted
Jul 22, 2020
Start date
Nov 28, 2020
Primary completion
Dec 20, 2021
Completion
May 1, 2022
Results posted
Aug 24, 2026
Last update
Aug 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion